Becton Dickinson and Company Company Profile
NYSE: BDXHealth CareMedical/Dental InstrumentsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Becton Dickinson at a glance
Becton Dickinson and Company (NYSE: BDX) is a Medical/Dental Instruments company in the Health Care sector headquartered in Franklin Lakes, NJ. Becton Dickinson is led by Mr. Thomas E. Polen Jr. and employs about 72,000 people. At a market capitalization of $49.11 billion, it is considered a large-cap company.
BDX is a member of the SP500. Its SEC Central Index Key (CIK) is 0000010795, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Becton Dickinson do?
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care settings to improve the safety of health care workers. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Business description based on the company's public filings.
Company information
- Legal name
- Becton Dickinson and Company
- Ticker
- NYSE: BDX
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Thomas E. Polen Jr.
- Employees
- 72,000
- Headquarters
- 1 Becton Drive, Franklin Lakes, NJ, United States
- Phone
- 201 847 6800
- Website
- bd.com
- Market cap
- $49.11B
- SEC CIK
- 0000010795
Index membership
Companies similar to Becton Dickinson
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MDLNMedline Inc. Class A | 35.45 | -0.28% | $47.70B | vs BDX |
| BSXBoston Scientific Corporation | 41.58 | -1.45% | $60.26B | vs BDX |
| DXCMDexCom Inc. | 84.30 | +1.09% | $31.81B | vs BDX |
| RMDResMed Inc. | 225.98 | +2.40% | $31.78B | vs BDX |
| WSTWest Pharmaceutical Services Inc. | 366.48 | -1.65% | $25.79B | vs BDX |
| SOLVSolventum Corporation | 85.88 | -1.33% | $14.62B | vs BDX |
| MMM3M Company | 162.12 | -0.93% | $83.61B | vs BDX |
| PENPenumbra Inc. | 316.35 | -0.22% | $12.46B | vs BDX |